Drug intelligence / Profile preview

Tiaochang Xiaoliu Granules

Development stage: Unknown
Lead developer: Guangdong Provincial Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Tiaochang Xiaoliu Granules is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Guangdong Provincial Hospital of Traditional Chinese Medicine. It is primarily investigated for the prevention of colorectal adenoma recurrence following endoscopic removal of polyps in adults. The formulation is designed to regulate intestinal function and inhibit the formation of new adenomas, adhering to TCM principles of addressing underlying imbalances associated with colorectal pathologies. It is currently being evaluated in multi-center, randomized, placebo-controlled clinical trials in China to establish its efficacy and safety as a long-term preventive therapy.

Other names: Tiaochang Xiaoliu Keli

Beyond the preview

Go deeper on Tiaochang Xiaoliu Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tiaochang Xiaoliu Granules.

Explore the full profile